In the BioHarmony Drug Report Database

"Preview" Icon

Simoctocog alfa

Nuwiq, Vihuma (simoctocog alfa) is a protein pharmaceutical. Simoctocog alfa was first approved as Nuwiq on 2014-07-22. It is used to treat factor VII deficiency, hemophilia a, hemorrhage, and von willebrand diseases in the USA. It has been approved in Europe to treat hemophilia a.

 

Trade Name

 

Nuwiq, Vihuma
 

Common Name

 

simoctocog alfa
 

ChEMBL ID

 

CHEMBL2108319
 

Indication

 

factor vii deficiency, hemophilia a, hemorrhage, von willebrand diseases
 

Drug Class

 

Image (chem structure or protein)

Simoctocog alfa structure rendering